Transmural remission improves clinical outcomes up to 5 years in Crohn's disease

INTRODUCTION: Evidence supporting transmural remission (TR) as a long‐term treatment target in Crohn's disease (CD) is still unavailable. Less stringent but more reachable targets such as isolated endoscopic (IER) or radiologic remission (IRR) may also be acceptable options in the long‐term. ME...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernandes, Samuel Raimundo, Serrazina, Juliana, Botto, Inês Ayala, Leal, Tiago, Guimarães, Andreia, Garcia, Joana Lemos, Rosa, Isadora, Prata, Rita, Carvalho, Diana, Neves, João, Campelo, Pedro, Ventura, Sofia, Silva, Andrea, Coelho, Mariana, Sequeira, Cristiana, Oliveira, Ana Paula, Portela, Francisco, Ministro, Paula, Tavares de Sousa, Helena, Ramos, Jaime, Claro, Isabel, Gonçalves, Raquel, Correia, Luís Araújo, Marinho, Rui Tato, Cortez‐Pinto, Helena, Magro, Fernando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Inflammatory Bowel Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892415/
https://www.ncbi.nlm.nih.gov/pubmed/36575615
http://dx.doi.org/10.1002/ueg2.12356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892415/
https://www.ncbi.nlm.nih.gov/pubmed/36575615
http://dx.doi.org/10.1002/ueg2.12356

Ejemplares similares